Related Experiment Videos
[Plasma levels of cyclic AMP and catecholamines in ischemic cerebrovascular disorders]
Archivio Per Le Scienze Mediche
|October 1, 1983
Insights
This study examined plasma catecholamine and cyclic adenosine monophosphate (cAMP) levels in patients with ischemic cerebrovascular diseases. Results indicate distinct levels between acute and chronic patients, suggesting prognostic value.
Area of Science:
- Neurology
- Biochemistry
- Cardiovascular Research
Background:
- Ischemic cerebrovascular diseases pose significant health challenges.
- Understanding disease progression markers is crucial for patient management.
- Plasma catecholamine and cAMP levels are implicated in various physiological processes.
Purpose of the Study:
- To investigate the relationship between clinical course in ischemic cerebrovascular disease patients and plasma catecholamine and cyclic adenosine monophosphate (cAMP) levels.
- To compare these levels in acute versus chronic patient cohorts.
Main Methods:
- Patient cohorts were divided into acute and chronic ischemic cerebrovascular disease groups.
- Plasma levels of catecholamines and cAMP were measured and compared between groups.
Main Results:
- Distinct patterns in plasma catecholamine and cAMP levels were observed between acute and chronic patient groups.
- These hematochemical parameters demonstrated differential behavior correlating with disease status.
Conclusions:
- Plasma catecholamine and cAMP levels exhibit different behaviors in acute and chronic ischemic cerebrovascular disease.
- These biomarkers may hold significant prognostic value for disease progression.
Abstract:
We evaluated in this study the relationships between the clinical course of patients affected with ischemic cerebrovascular diseases and plasma catecholamine and cAMP levels. We compared two groups of acute and chronic patients. These results show a different behaviour of plasma catecholamine and cAMP levels. This hematochemical parameter might assume a distance prognostic significance.